Search / Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company

Senior Director, DMPK Project Leader

Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company · Boston, MA

director $200k – $215k / year seen live 1 day ago

Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Centessa’s lead

Apply on Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company 's site

This link goes straight to the employer's greenhouse page. Posted 25 days ago.We last confirmed it was open 1 day ago.